Carregant...
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients with Type 2 Diabetes: A Randomized Trial
RATIONALE & OBJECTIVE: Hyperuricemia is implicated in the development and progression of chronic kidney disease (CKD). Verinurad is a novel, potent, specific urate reabsorption inhibitor. We evaluated the effects of intensive urate-lowering therapy with verinurad combined with the xanthine oxida...
Guardat en:
| Publicat a: | Am J Kidney Dis |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045740/ https://ncbi.nlm.nih.gov/pubmed/33130235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2020.09.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|